Shots:

• Roche has acquired Stratos Genomics to facilitate the development of its nanopore sequencer to provide the healthcare community and ultimately patients with faster and cheaper clinical diagnostic testing
• The acquisition provides Roche access to Stratos Genomics unique chemistry- Sequencing by Expansion (SBX). The addition of the SBX chemistry is expected to provide the HCPs an affordable- fast and flexible result- for multiple targeted clinical applications along with whole-exome and whole-genome sequencing
• Stratos Genomics will continue its operations in Seattle- Washington- US. Gene sequencing technology plays a critical role in personalized healthcare and clinical diagnostics of the future

Click here ­to­ read full press release/ article 

Ref: Roche | Image: Roche